Syntimmune is developing novel therapies for inflammatory diseases and life-threatening toxicities.

TargAnox, is an early-stage discovery company developing novel therapeutics for the treatment of diseases and conditions that result from oxidative stress-induced modification of proteins.

VisionScope Technologies, LLC manufactures a family of patented sub-2-mm diameter needle endoscopes with disposable optics and sterile barrier sheaths for diagnostic and minimally invasive surgical (MIS) applications. The product enables arthroscopy surgeons to visualize, diagnose and plan surgical procedures within several minutes in one single office appointment, thereby substantially reducing the number of physician appointments…

Provasculon (acquired by Mesoblast) was formed to develop new therapeutic agents for addressing wound healing, peripheral vascular disease and myocardial infarction damage.

Quartet Medicine is a biotechnology company focused on the development of novel treatments for chronic pain and inflammation.

QPID Health is a clinical intelligence platform designed to extract meaningful clinical information at the patient level from any electronic health record (EHR) through a unique and powerful medical concept based NLP (Natural Language Processing) search engine. The technology extracts from the EHR data repository and highlights for caregivers the most relevant clinical information at…

Annovation Biopharma was founded to create safer and easier-to-administer general anesthetic agents with financing led by Mass General Brigham Innovation Fund. The company was acquired upon demonstration of clinical proof of concept by The Medicines Company in 2015.

BioBehavioral Diagnostics (acquired by Pearson) was formed in 2004 to develop instrumentation for objective assessment and management of Attention Deficit Hyperactivity Disorder (ADHD), including medication response. The technology utilizes a set of proprietary bio-surrogate measurements to enable the accurate assessment and management of ADHD.

CoStim developed novel biologics targeting immune checkpoint inhibitors for oncology indications. CoStim was acquired by Novartis in 2014.

Daktari Diagnostics is focused exclusively on the most pressing challenges in global health. The company develops simple, accurate, and affordable products that deliver critical diagnostic information to clinicians and patients across the globe.

Denali Therapeutics is a biotechnology company focused on the discovery and development of therapies for patients with neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s disease, ALS and others. Denali was founded by scientists, industry experts and investors who share the vision that recent scientific insights into the genetic causes and biological processes underlying neurodegenerative disease, together…

Editas Medicine, a genome editing company, is exploring the possibility to modify, in a targeted way, almost any gene in the human body with the ability to directly turn on, turn off or edit disease-causing genes. Editas’ mission is to translate its genome editing technology into a novel class of human therapeutics that enable precise…